Serum apelin levels and body composition changes in breast cancer patients treated with an aromatase inhibitor.

@article{Salman2016SerumAL,
  title={Serum apelin levels and body composition changes in breast cancer patients treated with an aromatase inhibitor.},
  author={Tarik Salman and Leyla Demir and Umut Varol and Murat Akyol and Utku Oflazoglu and Y. Kemal Yildiz and Halil Taşkaynatan and Hakan Cengiz and Guven Guvendi and Yuksel Kucukzeybek and Ahmet Alacacioğlu and Oktay Tarhan},
  journal={Journal of B.U.ON. : official journal of the Balkan Union of Oncology},
  year={2016},
  volume={21 6},
  pages={
          1419-1424
        }
}
PURPOSE The adipose tissue plays a role in carcinogenesis with the adipokines it generates. Apelin is an anti-obesigenic adipokine, and assumes roles in both vascularization and tumor cell proliferation. The present study aimed to investigate changes in apelin levels, in postmenopausal breast cancer (BC) patients receiving aromatase inhibitors (AIs). METHODS Forty early-stage postmenopausal BC patients treated with AIs with no history of chemotherapy administration were included in the study… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 44 REFERENCES